Cargando…

Successful Treatment of a Patient with Giant Cell Vasculitis (Horton Arteritis) with Tocilizumab a Humanized Anti-Interleukin-6 Receptor Antibody

Giant cell arteritis (GCA) is the most common form of systemic vasculitis in adults, affecting preferentially medium-large size arteries. Here we report a case of a female with a diagnosis of GCA based on temporal artery biopsy, successfully treated with tocilizumab, a humanized anti-interleukin-6 r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lurati, Alfredomaria, Bertani, Luca, Re, Katia Angela, Marrazza, Mariagrazia, Bompane, Daniela, Scarpellini, Magda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420619/ https://www.ncbi.nlm.nih.gov/pubmed/22937454 http://dx.doi.org/10.1155/2012/639612

Ejemplares similares

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab
por: Lurati, Alfredomaria, et al.
Publicado: (2012)

Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Lurati, Alfredomaria, et al.
Publicado: (2010)

The macrophages in rheumatic diseases
por: Laria, Antonella, et al.
Publicado: (2016)

Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up
por: Laria, Antonella, et al.
Publicado: (2017)

Calciphylaxis in a patient affected by rheumatoid arthritis, chronic renal failure, and hyperparathyroidism: a case report
por: Lurati, Alfredomaria, et al.
Publicado: (2015)

Role of temporal artery resection in Horton's arteritis (Review)
por: Vrinceanu, Daniela, et al.
Publicado: (2021)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

Giant Cell Arteritis With Chronic Bronchitis Successfully Treated With Tocilizumab
por: Ohta, Ryuichi, et al.
Publicado: (2023)

Different T cells’ distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study
por: Lurati, Alfredomaria, et al.
Publicado: (2015)

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati, Alfredomaria, et al.
Publicado: (2021)

User preference for a portable syringe pump for iloprost infusion
por: Laria, Antonella, et al.
Publicado: (2015)

Relationship between NK Cell Activation and Clinical Response in Rheumatoid Arthritis Treated with Rituximab
por: Lurati, A., et al.
Publicado: (2009)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)

Vision loss in patients with giant cell arteritis treated with tocilizumab
por: Amsler, Jennifer, et al.
Publicado: (2021)

Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)

Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis
por: Seitz, Luca, et al.
Publicado: (2021)

Atypical Cogan's Syndrome Mimicking Giant Cell Arteritis Successfully Treated with Early Administration of Tocilizumab
por: Hara, Kazusato, et al.
Publicado: (2021)

Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report
por: Cho, Young Min, et al.
Publicado: (2023)

Profile of tocilizumab and its potential in the treatment of giant cell arteritis
por: Mollan, Susan Patricia, et al.
Publicado: (2018)

Vasculitis with granulomatosis: An atypical presentation of giant cell arteritis
por: Dao, Diem-Phuong, et al.
Publicado: (2021)

Giant cell arteritis with stroke and systemic diffuse vasculitis
por: Lu, C, et al.
Publicado: (2022)

Horton on Diseases of the Tropics
Publicado: (1875)

The Horton Infirmary, Banbury
Publicado: (1916)

Tocilizumab for relapsing and remitting giant cell arteritis: a case series
por: Saha, Pratyasha, et al.
Publicado: (2022)

Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the “Magenta osteoarthritis study”
por: Scarpellini, M., et al.
Publicado: (2008)

Giant cell arteritis: A rare cause of posterior vasculitis
por: Moschos, Marilita M, et al.
Publicado: (2009)

William S. Horton : Impresionista Norteamericano = American Impressionist
por: Horton, William S., 1865-1936
Publicado: (1991)

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
por: Samson, Maxime, et al.
Publicado: (2021)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Ivor Horton's Beginning Java
por: Horton, Ivor
Publicado: (2011)

Dr. David B. Horton
Publicado: (1906)

Dr. Eugene B. Horton
Publicado: (1912)

Dr. Levi E. Horton
Publicado: (1912)

The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis
por: Conticini, Edoardo, et al.
Publicado: (2020)

Extra- and Intracranial Cerebral Vasculitis in Giant Cell Arteritis: An Observational Study
Publicado: (2015)

Extra- and Intracranial Cerebral Vasculitis in Giant Cell Arteritis: An Observational Study
por: Larivière, Delphine, et al.
Publicado: (2014)

55. A case for continuing tocilizumab beyond 12 months in giant cell arteritis?
por: Ming, Caroline, et al.
Publicado: (2019)

Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
por: Butryn, Michaela, et al.
Publicado: (2021)

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
por: Loricera, Javier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3l74vvombufovgegellc1jv1ru